News Business Psilocybin
Red Light Holland’s largest psilocybin shipment received by CCrest Labs in Montreal with Health Canada approved import permit

(Newsfile) Toronto — Red Light Holland Corp., a company engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe and a premium brand of psilocybin truffles to the legal, recreational market within the Netherlands, in compliance with all applicable laws, is pleased to announce significant progress in its collaboration with CCrest Laboratories Inc., a cGMP-certified pharmaceutical laboratory based in Montreal, which possesses a Controlled Drugs and Substances Dealer’s License and PharmAla Biotech Holdings Inc., following the successful shipment of psilocybin truffles to Canada.

On April 8th, 2024, Red Light Holland initiated its largest shipment to date, sending 5 kg (5,000 grams) of freshly cultivated natural psilocybin truffles from its farm in the Netherlands to CCrest Labs in Montreal, Canada. This milestone shipment, facilitated by a 5th Health Canada approved psilocybin import permit, marks a pivotal moment in the company’s commitment to advancing psychedelic research.

“We are excited to continue our work with CCrest Laboratories and PharmAla as we delve deeper into the therapeutic potential of psilocybin,” said Todd Shapiro, CEO and director of Red Light Holland. “This largest and most significant shipment to date, underscores our dedication to research and development in the psychedelic space. We anticipate near term insights and updates to emerge from this collaboration.”

The truffles will be utilized in an experimental research project aimed at developing a process for commercial manufacturing of natural-source Active Pharmaceutical Ingredient (API) derived from Red Light Holland’s psilocybin truffles. This project represents a critical step towards expanding access to standardized psilocybin products and exploring their potential therapeutic applications.